LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED RECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED RECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study is testing whether adding two targeted drugs (tucatinib and trastuzumab) to standard chemotherapy before surgery can help shrink tumors in people with a specific type of rectal cancer (HER2-positive). The main goal is to see if this combination leads to a complete disa…
Matched conditions: LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims to shrink rectal tumors without chemo
Disease control Recruiting nowThis study is testing whether two immunotherapy drugs (botensilimab and balstilimab) can shrink rectal tumors before surgery. Researchers want to see if this approach works for people with a specific type of rectal cancer that doesn't typically respond well to immunotherapy. The …
Matched conditions: LOCALLY ADVANCED RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC